Biotech Digest – GMED Receives Clearance, BIOC Inks New Collaboration, PFE Receives Approval
August 18, 2017 at 15:03 PM EDT
Globus Medical Inc. stock perked up as the company announced receiving the 510 (k) clearance from the FDA for Excelsius GPS. AstraZeneca announced receiving the FDA approval for its Lynparzaa. Pfizer has FDA approval for its Besponsa.
